← All stocks

Nautilus Biotechnology, Inc.

NAUT No buying or selling
CIK 0001808805 #4256 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

7 insiders · 0 transactions
45.5×

Sujal Patel holds 45.5 times base salary in stock. $24.36M of shares against $535.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Sujal Patel last reported holding, valued at $2.35, the price Common Stock was last bought or sold at on the open market here, on 2 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Mallick Parag
Chief Scientist
20,493,392
$48.16M
+0.1%
Patel Sujal M
CEO, President, and Secretary
10,366,721
$24.36M
+3.0%
AH Equity Partners Bio II, L.L.C. entity
10% owner
971,885
$2.28M
−83.7%
Mowry Anna
CFO and Treasurer
83,000
$195.05K
+22.1%
Murphy Matthew B.
General Counsel
74,140
$174.23K
+36.9%
Suzuki Kentaro
Chief Marketing Officer
4,000
$9.40K
Godwin Mary E.
Senior VP, Operations
0
$0.00

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 11 Aug 2020